Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint Venture
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lumexa Imaging (Nasdaq: LMRI) announced a new joint venture with Advocate Health that marks its entry into Illinois. The agreement expands their existing partnership to extend Lumexa’s outpatient imaging services into the state. Lumexa now has 10 joint ventures with 9 health systems.
The company describes the Illinois venture as part of its geographic expansion strategy, which includes health system partnerships, development of new facilities and acquisitions.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointNew Advocate Health joint venture expands the existing partnership and marks Lumexa’s entry into Illinois.
Negative
- None.
Details
Market move: LMRI -3.73% vs previous close. Illinois joint venture
On Nov 12, the day this news came out, the latest delayed price for LMRI is 3.73% below the previous close. Our momentum scanner has recorded 9 alerts for this stock so far that day. The latest delayed price is $15.36.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Joint ventures
- 10 joint ventures
- Following the new Illinois agreement
- Health systems
- 9 health systems
- Lumexa’s joint venture network
Previous Partnership Reports
-
Earlier New York joint venture with HSS was Lumexa’s ninth JV and expanded its metro presence.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
10th Health System joint venture expands Lumexa Imaging’s geographic footprint and advances its disciplined growth strategy
RALEIGH, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest outpatient imaging providers, today announced a new joint venture with Advocate Health to expand its outpatient imaging services in Illinois. The agreement builds on the existing partnership and marks Lumexa Imaging’s entry into Illinois.
With this agreement, Lumexa Imaging now has 10 joint ventures with 9 health systems, reflecting continued execution of its strategy to expand its presence in attractive healthcare markets and bring high-quality, convenient care closer to patients and referring providers.
“Expanding our relationship with Advocate Health into Illinois is an important milestone for our company,” said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. “Our demonstrated success partnering with health systems is a key differentiator as health systems look to expand their outpatient imaging capabilities and participate in the shift toward lower-cost settings. We look forward to bringing our clinical and operational expertise to Illinois as we establish our presence in this new geography.”
The new Illinois joint venture advances Lumexa Imaging’s disciplined geographic expansion strategy, which includes health system partnerships, de novo development, and acquisitions. The company remains focused on deploying capital efficiently in markets where it sees opportunities for sustainable, long-term growth.
About Lumexa Imaging
Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and approximately 190 outpatient imaging centers, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “goal,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” or “will,” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements in this release include, but are not limited to, statements regarding our expectations, goals, strategies and long-term objectives, including our ability to drive future growth, expand our outpatient imaging center footprint, execute on our health system partnership strategy, capitalize on market trends and demand, and realize the expected benefits of strategic joint ventures. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including but not limited to those risk factors identified in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our Annual Report on Form 10-K for the year ended December 31, 2025 and our later dated Quarterly Reports on Form 10-Q, each as filed with the Securities and Exchange Commission. The forward-looking statements in this press release are based on information available to us as of the date hereof, and we disclaim any obligations to update any forward-looking statements, except as required by law.
Media Contact
Melissa Weston
Melissa.Weston@LumexaImaging.com
Investors
Sue Dooley
sue.dooley@Lumexaimaging.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Lumexa Imaging’s new Advocate Health joint venture cover?
The new joint venture expands Lumexa’s outpatient imaging services into Illinois. It builds on the companies’ existing partnership and marks Lumexa’s entry into the state.